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The discovery of the new world, in 1492, by Christopher Columbus, brought about a 
revolution in both spirit and mentalities. Progressive knowledge of it conditioned many 
activities, giving rise to the vast Spanish American empire, which lasted for more than 
three hundred years. The data that have been collected, despite all uncertainties, show us 
a vast, incredible and varied world full of natural riches. The information that has come 
down to us, through more than five hundred years, still awakens interest among 
historians. The sources are varied and of heterogeneous significance. But, taken 
together, they enable us to see an integrated panorama. 
Various main blocks of sources that have concerned the specialists can be differentiated. 
Logically, the first documents are the diaries and writings of Columbus himself and 
related texts. Next comes the Chronicles of the Histories of the Indies. They provided 
extraordinary information that never ceased to amaze Renaissance society, which 
welcomed them enthusiastically. 
By the middle of the 16th century a hundred or so plants with various uses had already 
been described. Among these were some thirty medicinal plants that have been difficult 
to identify from the documents, but have been clarified by knowledge of the daily 
practice. 
This information in the Chronicles of the Indies was concretised and consolidated in 
two fundamental scientific texts, the books of Nicolás Monardes and the immense work 
of Francisco Hernández, on which there are excellent studies. In turn these works were 
the basis for many others.  
Other information that has reached us from the American Materia Medica comes from 
Royal instructions and documentation from the Administration of the Indies. All this 
documentation shows that the whole process of discovery and colonization was a policy 
mediated and directed by the Crown. The Royal Warrant granted by Philip II, in 
January 1570, appointing “Protomédicos” for the Indies established centralized laws 
over the organization of American medicine and gave an express mandate that 
information on medicinal plants, wherever found, should be sent back to Spain, ordering 
that experiments and all possible trials should be carried out. 
The Relaciones de Indias also initiated in the time of Philip II, are the result of 
statistical, historical, geographical and administrative work. They are vital historical 
sources for all fields. All this scattered and heterogeneous information reached the most 
important medical and pharmaceutical authors, who tried to assimilate the therapeutic 
novelties of the American drugs in medical and pharmaceutical texts. 
 
Private account and the enormous mass of documents relating to the actions of the 
religious orders occupy a special place in the sources. We are far from integrating this 
inexhaustible source of information.  
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It also opened up an impressive field for naturalists. The new drugs that arrived from 
America had to be observed, described and tested; Monardes, Clusius and Valerius 
Cordus played outstanding parts in this task. The most useful materials of our naturalists 
such as Hernández, Sessé, Ruiz y Pavón, Celestino Mutis, etc. were filed away and dis-
persed before they became known. They are a series of documents of the greatest 
importance for the history of science in general. 
Following the route in which American drugs were incorporated into medical and 
pharmaceutical scientific texts requires a differentiated level of knowledge that is 
essential if we are to make any type of evaluation. It seems that the appearance of 
Monardes’ complete work in 1574, describing close to a hundred American drugs, 
should mark the path of transmission, assimilation and greater awareness of such 
information. However, the analysis of Spanish books of the 16th and 17th centuries 
presents a desolating panorama; the pharmaceutical texts of the 17th century speak of 
only eight fundamental drugs of American origin. We have to wait until well into the 
18th century for wider information about American drugs.  
A special and extremely suggestive chapter is made up of the medical missionaries’ 
herbaria and some of the Hospital formularies are of great medical and historic 
significance. 
As could have been expected, it was only at the beginning of the 18th century that there 
is reference to a significant range of American drugs. Eighteen drugs are represented; 
that would form the nucleus of the principal medical and pharmaceutical textbooks. The 
situation is even less comprehensible when we realise that American drugs enjoyed 
greater acceptance and diffusion in Europe than in Spain, in spite of information about 
them being indirect and dependent on the Spanish trade monopoly. The edition of the 
Dispensatorium of Valerius Cordus of 1592, that is, a hundred years after the discovery 
of America, refers to ten drugs, and, fifteen new drugs are incorporated in the 1666 
edition 
Nicolás Lémery, at the end of the 17th century, provides us with an excellent picture of 
the knowledge of drugs at that time, including those of American origin. Another great 
pharmaceutical text, the Dispensatorium Branderburgicum (1698), gives thirteen 
American drugs, and in successive editions, until 1781, over the years, lists twenty-six 
drugs of American origin, sometimes more, sometimes fewer. The Pharmacopoeia 
Edinburguensis (1784) has a similar content. The Pharmacopoeia Matritensis I (1739) 
includes 21 drugs from American plants. It is a very representative selection, which 
appears in the great majority of the world’s pharmacopoeias. 
From the end of the 18th century, logically, the extent of the incorporation of new drugs 
of American origin is very different and requires special consideration. In Spanish 
pharmacopoeias, similarly to other pharmacopoeias, a further 33 drugs, with slight 
differences, were in incorporated. The Pharmacopoeia Germanica” I (1872) describes 
thirty-two American drugs. It is not a question of including one more or one less drug in 
the inventory. Rather it is to search in the texts for the more permanent and widely used 
drugs in this therapeutic arsenal 
Yet we must not forget that the most important factor is the real of the use of American 
drugs. It is without doubt, in research terms, of enormous significance and yet, 
paradoxically, the one to which the specialists have paid least attention. It is the final 
link in the chain but no less important for that. It marks the difference between the level 
of scientific knowledge and the degree to which the drugs were really used.  
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The level of development of the cities would be a decisive factor. In this sphere, any 
geographical generalization is a clear error. 
The inventories of medicines and, above all, the accounts of medicines made up and 
dispensed in hospitals, are evidence of unquestionable importance. The prescriptions 
and accounts represent the true level of therapeutics. Significant data have been 
established on the first appearance of American drugs, the time they remained in use 
and their disappearance. The real level of use, as was to be expected, is slight. In the 
Royal Hospital of Granada, from its foundation, at the beginning of the 16th century, 
there appears the continuous use only of Guaiacum wood and Sarsaparilla root. In the 
accounts of the Royal Pharmacy of Madrid, in 1544, only Guaiacum appears to be used; 
in 1573: Anami gum; Amyris carana Humb; Guaiacum wood; Bursera tomentosa and 
Sarsaparilla root 
 
 In a private Pharmacy in Madrid, in 1570, reference is made to Convolvulus 
mechoacana Vitm. From 1617, in the Hospital of Antequera, only seven American 
drugs are mentioned. In 1626 Sassafras appears on the scene 
 
The case of Cinchonas is the most studied and controversial. It is accepted that quinine 
arrived in Italy in 1632; some authors state that it was sold in Spain from 1638. Dr. 
Bravo de Sobremonte, in 1649, makes mention of Cinchona. The widespread and 
continuous use of Cinchona Officinalis does not appear in the Hospital of Antequera 
until 1697. The situation in the hospitals of Seville and Cadiz were, logically, somewhat 
different. The uninterrupted presence of ipecacuanha is only found after 1745, in the 
College of the Company of Jesus in Madrid. These are only examples, but significant. 
In the 18th century we have abundant information about the distribution of Cinchona 
from the Royal Pharmacy as a charity to many hospitals throughout the country and to 
foreign Courts.  
First the Royal Pharmacy, and afterwards the Botanical Gardens of Madrid, are two 
of the Royal Institutions that drove and coordinated the scientific work. Trials of drugs 
were widely practiced in the Hospitals.  
A complementary source is the reports on the trade in American drugs. These are 
decisive for the true evaluation of the presence of American drugs in Spanish and 
European therapeutics. 
